Multicopper oxidase mutant with improved salt tolerance

US11008552B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11008552-B2
Application numberUS-201916524382-A
CountryUS
Kind codeB2
Filing dateJul 29, 2019
Priority dateMay 24, 2019
Publication dateMay 18, 2021
Grant dateMay 18, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides a multicopper oxidase mutant with improved salt tolerance. Threonine at site 317 of wild-type multicopper oxidase WT was mutated to asparagine, leucine at site 386 was mutated to tyrosine, and serine at site 427 was mutated to glutamic acid by site-directed mutagenesis to obtain a mutant T317N-L386Y-S427E. Compared with WT, the tolerance of T317N-L386Y-S427E to 6%, 9%, 12%, 15% and 18% NaCl (W/V) is improved.

First claim

Opening claim text (preview).

What is claimed is: 1. A multicopper oxidase mutant, wherein: (a) the multicopper oxidase mutant comprises the amino acid sequence SEQ ID NO:1, or (b) the multicopper oxidase mutant comprises the amino acid sequence SEQ ID NO:1 with residue number 110 mutated to glutamic acid (A110E), and wherein the multicopper oxidase mutant possesses oxidase enzymatic activity. 2. A method for producing a multicopper oxidase mutant comprising: inoculating a genetically engineered bacterium transformed with a gene encoding a multicopper oxidase mutant of claim 1 into a medium; inducing the genetically engineered bacterium to express the gene; collecting the genetically engineered bacterium; disrupting the genetically engineered bacterium; and purifying the multicopper oxidase mutant from the disrupted genetically engineered bacterium. 3. The method according to claim 2 , which further comprises: adding the purified multicopper oxidase mutant to a food, thereby removing biogenic amines in the food by degradation. 4. The method according to claim 3 , wherein the food comprises soy sauce. 5. The method according to claim 3 , wherein the biogenic amine comprises at least one of tryptamine, phenethylamine, putrescine, cadaverine, histamine, tyramine, spermine and spermidine.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11008552B2 cover?
The present disclosure provides a multicopper oxidase mutant with improved salt tolerance. Threonine at site 317 of wild-type multicopper oxidase WT was mutated to asparagine, leucine at site 386 was mutated to tyrosine, and serine at site 427 was mutated to glutamic acid by site-directed mutagenesis to obtain a mutant T317N-L386Y-S427E. Compared with WT, the tolerance of T317N-L386Y-S427E to 6…
Who is the assignee on this patent?
Univ Jiangnan
What technology area does this patent fall under?
Primary CPC classification C12N9/0004. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).